Methyl hydrazinecarbimidothioate hydroiodide
CAS: 35600-34-1
Ref. 3D-FM133227
| 1g | To inquire | ||
| 2g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 25g | To inquire |
Product Information
- Hydrazinecarboximidothioic acid methyl ester hydroiodide
- Carbamohydrazonothioic Acid, Methyl Ester
Methyl hydrazinecarbimidothioate hydroiodide (MHCDI) is an anti-cancer drug that belongs to the group of alkylating agents. It is a prodrug that must be activated by intramolecular hydrogen chloride to form methyl hydrazine, which reacts with the DNA nucleotide bases. MHCDI is used in clinical studies for the treatment of pancreatic cancer, colorectal cancer, and other cancers. MHCDI is administered intravenously, orally, or intraperitoneally. MHCDI binds to nitrogen atoms in the vasoactive intestinal peptide and reacts with hydrochloric acid to form a pyrazole ring. The reaction products are then excreted from the body.
Chemical properties
Technical inquiry about: 3D-FM133227 Methyl hydrazinecarbimidothioate hydroiodide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
